ARCHIVES

Critics of FDA misunderstand Bayesian analysis, statisticians say.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Groups Have No Budgets As NCTN Begins Work March 1

February 28, 2014

IARC Publishes Fourth Edition of European Code Against Cancer

October 17, 2014

DCT Board Approves Recompetition Of Clinical Trials, Other Contracts, New BNCT Grants

October 28, 1988

In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General

October 28, 1994

Gleevec Approved For Pediatric CML

May 23, 2003

In Brief: Auto Workers Not At Increased risk Of Bladder Cancer, But Truck Drivers Are, New Study Shows

March 11, 1983